Table.
Unadjusted Percentage of Women Receiving New Osteoporosis Drug Therapy
| No. (%) |
||||||||
|---|---|---|---|---|---|---|---|---|
| Dual-Energy X-ray Absorptiometry Resulta |
||||||||
| Total |
No Osteoporosis |
Non-Main-Site Osteoporosis |
Main-Site Osteoporosis |
|||||
| Age | No. | New Treatmentb | No. | New Treatmentb | No. | New Treatmentb | No. | New Treatmentb |
| 40-64 y | ||||||||
|
| ||||||||
| Low-risk | 3696 (60.1) | 913 (24.7) | 2246 (60.8) | 179 (8.0) | 1092 (29.6) | 469 (43.0) | 358 (9.7) | 265 (74.0) |
|
| ||||||||
| Elevated risk | 927 (15.1) | 289 (31.2) | 512 (55.2) | 52 (10.1) | 289 (31.2) | 147 (50.9) | 126 (13.6) | 90 (71.4) |
|
| ||||||||
| ≥65 y | 1527 (24.8) | 710 (46.5) | 505 (33.0) | 80 (15.8) | 635 (41.6) | 345 (54.3) | 387 (25.3) | 285 (73.6) |
|
| ||||||||
| Total | 6150 (100) | 1912 (31.1) | 3263 (53.1) | 311 (9.5) | 2016 (32.8) | 961 (47.7) | 871 (14.2) | 640 (73.5) |
a
No osteoporosis indicates all sites normal or osteopenia without osteoporosis; non-main-site osteoporosis indicates lateral lumbar or other site osteoporosis.
b
P < .001 for χ2 test assessing overall difference in percentages of women who received new treatment with drugs by age-risk category.